KR20160055292A - MANUFACTURE OF FERMENTED Allium hookeri FROM YEASTS AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST - Google Patents
MANUFACTURE OF FERMENTED Allium hookeri FROM YEASTS AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST Download PDFInfo
- Publication number
- KR20160055292A KR20160055292A KR1020140154145A KR20140154145A KR20160055292A KR 20160055292 A KR20160055292 A KR 20160055292A KR 1020140154145 A KR1020140154145 A KR 1020140154145A KR 20140154145 A KR20140154145 A KR 20140154145A KR 20160055292 A KR20160055292 A KR 20160055292A
- Authority
- KR
- South Korea
- Prior art keywords
- fermented
- extract
- yeast
- present
- allium hookeri
- Prior art date
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 15
- 102000004190 Enzymes Human genes 0.000 title claims description 19
- 108090000790 Enzymes Proteins 0.000 title claims description 19
- 238000002360 preparation method Methods 0.000 title claims description 5
- 241001513212 Allium hookeri Species 0.000 title abstract description 8
- 230000035922 thirst Effects 0.000 title abstract description 7
- 238000010791 quenching Methods 0.000 title abstract description 4
- 238000004519 manufacturing process Methods 0.000 title description 11
- 230000000171 quenching effect Effects 0.000 title 1
- 239000000284 extract Substances 0.000 claims abstract description 42
- 238000000034 method Methods 0.000 claims abstract description 28
- 230000032683 aging Effects 0.000 claims abstract description 14
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 238000000855 fermentation Methods 0.000 claims description 49
- 230000004151 fermentation Effects 0.000 claims description 49
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 37
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 35
- 239000008213 purified water Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 238000001035 drying Methods 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 240000006439 Aspergillus oryzae Species 0.000 claims description 8
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims description 8
- 241000877401 Saccharomyces ellipsoideus Species 0.000 claims description 8
- 240000008042 Zea mays Species 0.000 claims description 7
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 7
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 7
- 235000008504 concentrate Nutrition 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 7
- 235000005822 corn Nutrition 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 235000020357 syrup Nutrition 0.000 claims description 6
- 239000006188 syrup Substances 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 150000004684 trihydrates Chemical class 0.000 claims description 5
- 229920000858 Cyclodextrin Polymers 0.000 claims description 4
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 2
- 210000003734 kidney Anatomy 0.000 claims description 2
- 239000009262 Puerariae Radix plant extract Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 abstract description 16
- 235000019640 taste Nutrition 0.000 abstract description 7
- 206010003210 Arteriosclerosis Diseases 0.000 abstract description 6
- 239000004480 active ingredient Substances 0.000 abstract description 6
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 6
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 4
- 241000219780 Pueraria Species 0.000 abstract description 4
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 3
- 241000756943 Codonopsis Species 0.000 abstract description 2
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 244000274050 Platycodon grandiflorum Species 0.000 abstract description 2
- 210000000577 adipose tissue Anatomy 0.000 abstract description 2
- 230000035622 drinking Effects 0.000 abstract description 2
- 229930182470 glycoside Natural products 0.000 abstract description 2
- 150000002338 glycosides Chemical class 0.000 abstract description 2
- 230000006872 improvement Effects 0.000 abstract description 2
- 210000000214 mouth Anatomy 0.000 abstract description 2
- 230000009467 reduction Effects 0.000 abstract description 2
- 240000001008 Dimocarpus longan Species 0.000 abstract 1
- 235000000235 Euphoria longan Nutrition 0.000 abstract 1
- 235000006751 Platycodon Nutrition 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 230000009089 cytolysis Effects 0.000 abstract 1
- 210000000936 intestine Anatomy 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 229930189914 platycodon Natural products 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 description 23
- 239000011593 sulfur Substances 0.000 description 23
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 22
- 235000010633 broth Nutrition 0.000 description 20
- 239000000243 solution Substances 0.000 description 8
- 241000208340 Araliaceae Species 0.000 description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 description 7
- 235000008434 ginseng Nutrition 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 235000012424 soybean oil Nutrition 0.000 description 5
- 239000003549 soybean oil Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 210000000476 body water Anatomy 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 240000002234 Allium sativum Species 0.000 description 3
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 230000002292 Radical scavenging effect Effects 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000004611 garlic Nutrition 0.000 description 3
- 239000004519 grease Substances 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 230000031891 intestinal absorption Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- CDDWAYFUFNQLRZ-KJVHGCRFSA-N (3beta,21beta,22beta)-olean-12-ene-3,21,22,24-tetrol Chemical compound C([C@@]12C)C[C@H](O)[C@](C)(CO)[C@@H]1CC[C@]1(C)[C@@H]2CC=C2[C@@H]3CC(C)(C)[C@@H](O)[C@@H](O)[C@]3(C)CC[C@]21C CDDWAYFUFNQLRZ-KJVHGCRFSA-N 0.000 description 2
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 2
- BYBNLTUPSXGVAV-UHFFFAOYSA-N 6-[[8a-[3-[5-[3,5-dihydroxy-4-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxycarbonyl-8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound OC1C(O)C(OC2C(C(OC3C(C(O)C(O)CO3)O)C(O)CO2)O)C(C)OC1OC1C(O)C(O)COC1OC(=O)C1(C(CC2(C)C3(C)CCC4C5(C)C)O)CCC(C)(C)CC1C2=CCC3C4(C)CCC5OC1OC(C(O)=O)C(O)C(O)C1O BYBNLTUPSXGVAV-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000238371 Sepiidae Species 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229940124595 oriental medicine Drugs 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000012925 reference material Substances 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- CDDWAYFUFNQLRZ-UHFFFAOYSA-N soyasapogenol A Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)C(O)C(O)C3(C)CCC21C CDDWAYFUFNQLRZ-UHFFFAOYSA-N 0.000 description 2
- 235000019654 spicy taste Nutrition 0.000 description 2
- -1 superoxide radicals Chemical class 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000000304 vasodilatating effect Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- ITYGLICZKGWOPA-UHFFFAOYSA-N (2R,3R,4S,5S,6R)-2-[[(3S,5S,9R,10S,13R,14R,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Natural products C1CC2(C)C3CCC4(C)C(C(C)C=CC(CC)C(C)C)CCC4C3=CCC2CC1OC1OC(CO)C(O)C(O)C1O ITYGLICZKGWOPA-UHFFFAOYSA-N 0.000 description 1
- JWDYCNIAQWPBHD-UHFFFAOYSA-N 1-(2-methylphenyl)glycerol Chemical compound CC1=CC=CC=C1OCC(O)CO JWDYCNIAQWPBHD-UHFFFAOYSA-N 0.000 description 1
- CNHZRRBWLMSLDX-WNHLAMKZSA-N 2''O-acetylplatycodin D Chemical compound O([C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2C1(CO)CO)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CNHZRRBWLMSLDX-WNHLAMKZSA-N 0.000 description 1
- HCXVJBMSMIARIN-ZETWWWAOSA-N 24alpha-Ethyl-koprostanol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C HCXVJBMSMIARIN-ZETWWWAOSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- YYNJYMYRHBOARL-UHFFFAOYSA-N 7-methoxyquinoxalin-5-amine Chemical compound N1=CC=NC2=CC(OC)=CC(N)=C21 YYNJYMYRHBOARL-UHFFFAOYSA-N 0.000 description 1
- 241000332371 Abutilon x hybridum Species 0.000 description 1
- 240000004246 Agave americana Species 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- KFFJPIQLAPHYBF-UHFFFAOYSA-N Azukisaponin V Natural products COC(=O)C1OC(OC2CCC3(C)C(CCC4(C)C3CC=C5C6CC(C)(C)CC(O)C6(O)CCC45C)C2(C)CO)C(OC7OC(CO)C(O)C(O)C7OC8OC(C)C(O)C(O)C8O)C(O)C1O KFFJPIQLAPHYBF-UHFFFAOYSA-N 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- NKMDIWKRKQFYPH-UHFFFAOYSA-N Lupan Natural products C1CCC(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(C)C)C5C4CCC3C21C NKMDIWKRKQFYPH-UHFFFAOYSA-N 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- ACCRBMDJCPPJDX-UHFFFAOYSA-N Methyl 3-hydroxyhexanoate Chemical compound CCCC(O)CC(=O)OC ACCRBMDJCPPJDX-UHFFFAOYSA-N 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- JYDNKGUBLIKNAM-UHFFFAOYSA-N Oxyallobutulin Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C(=C)C)C5C4CCC3C21C JYDNKGUBLIKNAM-UHFFFAOYSA-N 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 239000008681 Phellinus linteus extract Substances 0.000 description 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- JFHRJMPZZYINAI-UHFFFAOYSA-N Soyasaponin I Natural products CC1OC(OC2C(O)C(O)C(CO)OC2OC3C(O)C(O)C(CO)OC3OC4CCC5(C)C(CCC6(C)C5CC=C7C8CC(C)(C)CC(O)C8(C)CCC67C)C4(C)CO)C(O)C(O)C1O JFHRJMPZZYINAI-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 241001414989 Thysanoptera Species 0.000 description 1
- KGGGRGBDMBZXKF-UHFFFAOYSA-N Virganreagenin G Natural products C1C(O)C(O)C(C)(CO)C2CCC3(C)C4(C)CC(O)C5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C KGGGRGBDMBZXKF-UHFFFAOYSA-N 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- BDCUGHMNUOTFKX-YJGMJMKZSA-N [(2s,3r,4s,5s)-3-[(2s,3r,4s,5r,6s)-5-[(2s,3r,4s,5r)-4-[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl] (4ar,5r,6ar,6as,6br,8ar,9r,10r,11s,12ar,14bs)-5,11-dihy Polymers O([C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2[C@@]1(CO)C)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O BDCUGHMNUOTFKX-YJGMJMKZSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- NVLPQIPTCCLBEU-UHFFFAOYSA-N allyl methyl sulphide Natural products CSCC=C NVLPQIPTCCLBEU-UHFFFAOYSA-N 0.000 description 1
- JZVFJDZBLUFKCA-FXIAWGAOSA-N alpha-Spinasterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-FXIAWGAOSA-N 0.000 description 1
- JZVFJDZBLUFKCA-UTQQLQBSSA-N alpha-spinasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-UTQQLQBSSA-N 0.000 description 1
- ITYGLICZKGWOPA-PYUVDJBBSA-N alpha-spinasterol glucoside Natural products CC[C@H](C=C[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C ITYGLICZKGWOPA-PYUVDJBBSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003502 anti-nociceptive effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- LPAJXALQNMJKEJ-UHFFFAOYSA-N aster saponin Hb Natural products CC1OC(OC2C(O)C(O)COC2OC(=O)C34CCC(C)(C)CC3C5=CCC6C7(C)CCC(OC8OC(C(O)C(O)C8O)C(=O)O)C(C)(C)C7CCC6(C)C5(C)CC4O)C(O)C(O)C1O LPAJXALQNMJKEJ-UHFFFAOYSA-N 0.000 description 1
- ZXFNMDBLCLWZIE-UHFFFAOYSA-N asterlingulatoside D Natural products OC1C(O)C(OC2C(C(OC3C(C(O)C(O)CO3)O)C(O)CO2)O)C(C)OC1OC1C(O)C(O)COC1OC(=O)C1(C(CC2(C)C3(C)CCC4C5(C)C)O)CCC(C)(C)CC1C2=CCC3C4(C)CCC5OC1OC(CO)C(O)C(O)C1O ZXFNMDBLCLWZIE-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- FVWJYYTZTCVBKE-ROUWMTJPSA-N betulin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FVWJYYTZTCVBKE-ROUWMTJPSA-N 0.000 description 1
- MVIRREHRVZLANQ-UHFFFAOYSA-N betulin Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5C(CCC5(CO)CCC34C)C(=C)C)C1(C)C MVIRREHRVZLANQ-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000002837 defoliant Substances 0.000 description 1
- 230000035613 defoliation Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- XEYBHCRIKKKOSS-UHFFFAOYSA-N disodium;azanylidyneoxidanium;iron(2+);pentacyanide Chemical compound [Na+].[Na+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].[O+]#N XEYBHCRIKKKOSS-UHFFFAOYSA-N 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000020 effect on hyperlipemia Effects 0.000 description 1
- HCFPRFJJTHMING-UHFFFAOYSA-N ethane-1,2-diamine;hydron;chloride Chemical compound [Cl-].NCC[NH3+] HCFPRFJJTHMING-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- DUJZKTGKEOIECZ-UHFFFAOYSA-N lancemaside B Natural products CC1OC(OC2C(OC(=O)C34CCC(C)(C)CC3C5=CCC6C7(C)CCC(OC8OC(C(O)C(O)C8O)C(=O)O)C(C)(C)C7CCC6(C)C5(C)CC4O)OCC(O)C2OC9OC(CO)C(O)C(O)C9O)C(O)C(O)C1OC%10OCC(O)C(OC%11OCC(O)C(O)C%11O)C%10O DUJZKTGKEOIECZ-UHFFFAOYSA-N 0.000 description 1
- BXHKXAJRNKNUAU-UHFFFAOYSA-N lancemaside C Natural products CC1OC(OC2C(OC(=O)C34CCC(C)(C)CC3C5=CCC6C7(C)CCC(OC8OC(C(O)C(O)C8O)C(=O)O)C(C)(C)C7CCC6(C)C5(C)CC4O)OCC(O)C2OC9OC(CO)C(O)C(O)C9O)C(O)C(O)C1OC%10OCC(O)C(O)C%10O BXHKXAJRNKNUAU-UHFFFAOYSA-N 0.000 description 1
- SIVLPOCXZDTMCP-UHFFFAOYSA-N lancemaside D Natural products CC1OC(OC2C(OC(=O)C34CCC(C)(C)CC3C5=CCC6C7(C)CCC(OC8OC(C(O)C(O)C8O)C(=O)O)C(C)(C)C7CCC6(C)C5(C)CC4O)OCC(O)C2OC9OC(CO)C(O)C(O)C9O)C(O)C(O)C1O SIVLPOCXZDTMCP-UHFFFAOYSA-N 0.000 description 1
- UBQNIALOTUBOSI-UHFFFAOYSA-N lancemaside E Natural products CC1OC(OC2C(O)C(O)COC2OC(=O)C34CCC(C)(C)CC3C5=CCC6C7(C)CCC(OC8OC(C(O)C(OC9OC(CO)C(O)C(O)C9O)C8O)C(=O)O)C(C)(C)C7CCC6(C)C5(C)CC4O)C(O)C(O)C1OC%10OCC(O)C(OC%11OCC(O)C(O)C%11O)C%10O UBQNIALOTUBOSI-UHFFFAOYSA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000010813 municipal solid waste Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- IVDSKBGNLNNRFN-UHFFFAOYSA-N platycodin A Natural products CC1OC(OC2C(O)C(O)COC2OC(=O)C34CCC(C)(C)CC3C5=CCC6C7(C)CC(O)C(OC8CC(CO)C(O)C(O)C8O)C(CO)(CO)C7CCC6(C)C5(C)CC4O)C(OC(=O)C)C(O)C1OC9OCC(O)C(OC%10OCC(O)(CO)C%10O)C9O IVDSKBGNLNNRFN-UHFFFAOYSA-N 0.000 description 1
- BDCUGHMNUOTFKX-DDRWPPTGSA-N polygalacin D Polymers O([C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2[C@]1(CO)C)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O BDCUGHMNUOTFKX-DDRWPPTGSA-N 0.000 description 1
- DJPJACADAIGMKF-CTELNEMLSA-N polygalacin-D Natural products O=C(O[C@H]1[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O[C@@]4(O)[C@H](O)[C@@](O)(CO)CO4)[C@H](O)CO3)[C@H](C)O2)[C@@H](O)[C@@H](O)CO1)[C@@]12[C@H](O)C[C@@]3(C)[C@@]4(C)[C@@H]([C@]5(C)[C@H]([C@@](CO)(C)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O)C5)CC4)CC=C3[C@@H]1CC(C)(C)CC2 DJPJACADAIGMKF-CTELNEMLSA-N 0.000 description 1
- 230000003658 preventing hair loss Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229940083618 sodium nitroprusside Drugs 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- PTDAHAWQAGSZDD-IOVCITQVSA-N soyasaponin I Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H](O[C@@H]([C@@H](O)[C@@H]2O)C(O)=O)O[C@@H]2[C@]([C@H]3[C@]([C@@H]4[C@@]([C@@]5(CC[C@@]6(C)[C@H](O)CC(C)(C)C[C@H]6C5=CC4)C)(C)CC3)(C)CC2)(C)CO)O[C@H](CO)[C@H](O)[C@@H]1O PTDAHAWQAGSZDD-IOVCITQVSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B7/00—Preservation or chemical ripening of fruit or vegetables
- A23B7/14—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10
- A23B7/153—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10 in the form of liquids or solids
- A23B7/154—Organic compounds; Microorganisms; Enzymes
- A23B7/155—Microorganisms; Enzymes; Antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/24—Synthetic spices, flavouring agents or condiments prepared by fermentation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/40—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by drying or kilning; Subsequent reconstitution
- A23L3/44—Freeze-drying
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/76—Yeasts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/66—Aspergillus
- C12R2001/69—Aspergillus oryzae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/85—Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/85—Saccharomyces
- C12R2001/865—Saccharomyces cerevisiae
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Abstract
Description
본 발명은 수종의 효모 및 천연효소 복합 발효액을 사용하여 삼채뿌리를 저온에서 발효시킨 후 숙성 및 건조과정을 거쳐 발효삼채를 제조한 다음, 발효삼채에 길경, 양유, 갈근 및 용안육 등을 배합하여 혼합음료로 제조함으로써, 과도한 운동, 육체적 과로, 심한 무더위, 건조한 환경, 과음 등으로 인한 갈증을 해소하고 구강이 건조해 지는 것을 예방하며 부족한 체내 수분을 보충하기 위한 혼합음료의 제조방법을 제공한다. The present invention relates to a method for producing fermented triangles by fermenting triangles roots at a low temperature by using a variety of yeast and natural enzyme complex fermentation broths and then aging and drying the fermented triangles and then mixing the fermented triangles with Gilang, Yangyu, The present invention provides a method of manufacturing a mixed drink for eliminating thirst due to excessive exercise, physical overload, severe heat, dry environment, and excessive drinking water, preventing the oral cavity from drying out, and replenishing insufficient body water.
삼채(Allium Hookeri)는 해발 1,400~4,200m의 고랭지에 자생하는 식물로 미얀마 등지에서는 국민채소로 알려져 있으며, 단맛, 쓴맛, 매운맛이 난다고 하여 삼채(三菜)라고 부르기도 하며, 인삼맛이 난다고 하여 삼채(蔘菜)라고 부르기도 한다. Allium Hookeri is a plant that grows in the highlands of 1,400 ~ 4,200m above sea level. It is also known as a national vegetable in Myanmar. It is also called "三 菜" because it has a sweet, bitter and spicy taste. It is also called "玄 菜".
2010년 국내 도입되어 2011년 경남 하동, 진주, 경기 하남등의 6곳에서 시험 재배에 성공하였고 2012년 김제시, 고창군, 신안군, 하동군, 제주도, 합천군 등에서 계약재배를 비롯해 강원, 충청, 경북, 경기 등의 약 1,000여 농가에서 재배하고 있다. In 2010, it was introduced in Korea and successfully cultivated in 6 places including Gyeongnam, Hadong, Jinju and Gyeongnam in 2011. Contract cultivation was started in Gimje, Gokchang, Sinan, Hadong, Jeju, Is cultivated in about 1,000 farms.
2012년 대량 재배를 시작하여 한국에서도 재배가 가능하다는 점이 입증되어 농촌지역의 신소득 작물로서 주목받고 있다. It has been proved that it can be cultivated in Korea since it started mass cultivation in 2012, and it is attracting attention as a new income crop in rural areas.
삼채는 우리나라의 파, 양파, 부추, 마늘처럼 쉽게 식용되고 있는 채소이고, 민간처방으로 다양한 염증질환과 암 질환 등에 사용되고 있으며, 우리나라에서 본격적인 재배는 약 3년 정도밖에 안되어 종근 관리 및 재배기술이 초보인 상태이다. 한편, 재배 기술의 미확립으로 2012년 폭염 및 가뭄으로 삼채의 재배과정에서 뿌리 썩음 증상 발생으로 상당히 큰 규모의 농가피해가 발생하기도 하였다. It is a vegetable that is easily edible like Korean wave, onion, leek and garlic. It is used for various inflammatory diseases and cancer diseases by private prescription. In Korea, the cultivation is only about 3 years. Respectively. On the other hand, due to the unconfirmed cultivation techniques, severe frost and drought in 2012 caused significant damage to the farms due to root rot symptoms during the cultivation of triplicate.
삼채는 마늘처럼 영양 번식하는 작물이나, 재배법의 미확립 등의 이유로 종근 가격이 고가로 형성되어 농가 경영비 상승요인이 되고 있다. The trash is a crop that nourishes like garlic, but the price of the root is high because of the fact that the cultivation method is not established.
식이 유황의 역할은 알파 및 감마-향정신성 진환(치매, 정신 박약), 베타-암 또는 만성질환(당뇨, 고혈압, 저혈압), 델타-피부질환(고엽제, 건선피부, 아토피 알레르기), 람다 및 뮤황-면역체계 강화 등 간기능개선 및 해독작용과 밀접한 관계가 있으며 인삼, 홍삼, 산삼, 선삼에는 베타황의 성분만 포함되어 있는 반면 삼채에는 6가지 성분 모두 들어있는 것으로 알려져 있다. The roles of dietary sulfur include alpha and gamma-psychotropic prophylaxis, beta-cancer or chronic diseases (diabetes, hypertension, hypotension), delta-skin disorders (defoliant, psoriasis skin, atopy allergies), lambda, It is known that ginseng, red ginseng, wild ginseng, and ginseng contain only beta-sulfur components, while all three components of ginseng contain all six components.
삼채의 주성분인 식이 유황은 산삼보다 60배 많은 사포닌이 함유되어 있고 1일 권장 섭취량은 평균 1,500mg이지만 식사를 통한 평균 섭취량은 23-30mg정도에 불과하다. Dietary sulfur, the main component of the trilobite, contains 60 times more saponin than the wild ginseng, and the recommended daily intake is 1,500 mg per day, but the average intake per meal is only about 23-30 mg.
삼채는 칼슘, 철, 아연, 망간 등 미네랄 성분과 함께 질소 및 섬유질이 풍부하게 함유되어 있어 골격과 치아형성, 혈액생성 및 정혈작용, 정력증강, 신체균형조절, 고혈압, 동맥경화, 변비예방 및 배변촉진 등 다양한 효능을 가진다. It is rich in nitrogen and fiber as well as minerals such as calcium, iron, zinc, and manganese, and is rich in nitrogen and fiber, so that bone and tooth formation, blood production and blood circulation, energetic enhancement, body balance control, hypertension, arteriosclerosis, And has various effects such as promotion.
유황은 인체를 구성하는 8대 영양소 중 1종으로 뼈의 골밀도를 높여줌으로써 뼈를 튼튼하게 해주고 골다공증을 예방하며 류마티스 관절염을 개선하는 효능을 나타낸다. Sulfur is one of the eight nutrients that constitute the human body. It increases the bone density of the bone, strengthens the bone, prevents osteoporosis, and improves rheumatoid arthritis.
유황성분은 피부의 조직을 서로 결집(S-S)시키는 접착제 역할을 함으로써 피부의 탄력을 유지시켜주고 세포 조직의 활성화로 검버섯과 기미 등이 엷어지며 피부미백효과가 뛰어나고 피부가 깨끗해지는 효능을 나타낸다. Sulfur ingredient acts as an adhesive that binds the tissues of the skin together (S-S), thereby maintaining the elasticity of the skin and activating the cell tissues, resulting in thinning of spots and stains, excellent skin whitening effect and cleansing effect of the skin.
유황은 혈관벽을 좁히는 주원인이 되는 콜레스테롤과 과산화지질을 분해시키는 기능을 가지고 있어 고지혈증, 동맥경화 및 혈전증에 탁월한 효과가 있는 것으로 알려져 있다. It has been known that sulfur has an excellent effect on hyperlipemia, arteriosclerosis and thrombosis due to its ability to decompose cholesterol and lipid peroxidation, which are main causes of narrowing the blood vessel wall.
항산화활성이 높은 유황은 체내 염증제거와 살균효과를 나타내며 관절염에도 효능을 가지고 있는 것으로 알려져 있다. Sulfur with high antioxidant activity is known to have the effect of eliminating inflammation and disinfection in the body and also in arthritis.
유황은 이뇨작용과 함께 변비를 억제하는 작용을 가지고 있고 탈모방지 및 모발생성에도 효능을 나타낸다. Sulfur has a diuretic action and constipation-inhibiting action, and it is also effective in hair loss prevention and hair generation.
국내에서 본격적으로 생산되는 삼채를 활용한 다양한 음식물의 개발이 요구되며, 또한, 삼채 대중화를 위해 삼채 고유의 마늘, 양파 냄새나 매운맛을 줄일 필요가 있을 것으로 사료된다.
It is necessary to develop diverse foods utilizing the triple hens produced in earnest in Korea and also it is necessary to reduce the odor and spicy taste of garlic,
삼채의 비린 냄새와 역겨운 맛을 개선하고, 항산화 활성을 증강시켜 항염효과, 고지혈증, 동맥경화, 뇌혈관 질환, 정신작용 개선, 체지방분해, 당뇨질환 등의 예방 및 개선시키는 방법을 제공하고자 한다. The present invention provides a method of preventing and improving anti-inflammatory effects, hyperlipidemia, arteriosclerosis, cerebrovascular disease, improvement of mental function, decomposition of body fat, diabetes mellitus, etc. by improving the odor and disgusting taste of the trifoliate and enhancing antioxidant activity.
본 발명은 삼채를 활용하여 갈증 해소용 음료를 제공하고자 한다. The present invention is to provide a beverage for relief of thirst using a three-ply sieve.
본 발명자들은 삼채를 추출하고 농축하는 과정에서 효소를 사용하여 배당체 성분을 비당체로 변화시킴으로써 유효성분의 항산화활성을 높이고, 장내 흡수를 촉진시켜 약효를 높였다. The present inventors increased the antioxidant activity of the active ingredient by increasing the glycoside component to an unglycoside by using an enzyme in the process of extracting and concentrating the triangle, thereby enhancing the drug efficacy by promoting intestinal absorption.
또한, 발효삼채 추출액에 길경, 양유, 갈근 및 용안육을 이상적으로 배합시킴으로써 과도한 운동, 육체적 과로, 심한 무더위, 건조한 환경, 과음 등으로 인한 갈증을 해소하고 구강이 건조해지는 것을 예방하며 부족한 체내 수분을 보충할 수 있는 처방 및 제조방법을 개발하였다. In addition, the ideal combination of Gyungyang, Yangyu, Punggyeon and Yongsangwang in Fermented Samcheok Extract to eliminate thirst due to excessive exercise, physical overwork, severe heat, dry environment, and excessive drinking water, prevent dry mouth and supplement insufficient body water And have developed a prescription and manufacturing method that can be applied.
이를 위해, 본 발명의 발효 삼채 제조방법은 효모 배양 농축분말과 과일효소 농축액을 혼합한 효모-효소 복합 발효액을 삼채에 넣어주는 단계, 상기 삼채를 발효시키는 단계 및 발효된 삼채를 소정 시간 숙성시킨 후 건조하는 단계를 포함한다. To this end, the method for preparing a fermented triangle according to the present invention comprises the steps of putting a yeast-enzyme complex fermentation broth in which a concentrated yeast culture powder and a fruit enzyme concentrate are mixed, fermenting the triplex and fermenting the fermented triplex for a predetermined time And drying.
또한, 본 발명의 발효삼채 제조방법은 효모 배양 농축분말과 과일효소 농축액을 혼합한 효모-효소 복합 발효액을 삼채(뿌리)에 침지하는 단계 ; According to another aspect of the present invention, there is provided a method for manufacturing a fermented triangle comprising the steps of: dipping a yeast-enzyme complex fermentation broth obtained by mixing a concentrated yeast culture powder and a fruit enzyme concentrate in a root;
발효조에 넣어 소정 시간 동안 1차 발효시키는 단계 ; Fermenting the fermented product in a fermenter for a predetermined period of time;
상기 효모 - 효소 복합 발효액을 상기 삼채에 분사하여 2차 발효하는 단계 ; 및 발효된 삼채를 소정 시간 숙성시킨 후 건조하는 단계를 포함한다. Injecting the yeast-enzyme complex fermentation broth onto the triplex to perform secondary fermentation; And aging the fermented trihydrate for a predetermined period of time, followed by drying.
또한, 본 발명은 발효삼채에 정제수를 가하고 가온 추출하여 수득한 발효 삼채 추출액 및 이를 포함하는 갈증해소용 음료를 제공한다. The present invention also provides a fermented tripe extract obtained by adding purified water to a fermented triangle and heating and extracting the same, and a low-thirsty beverage containing the same.
본 발명은 삼채로부터 생약 성분을 추출하고 농축하는 과정에서 효소-효모 복합체를 사용하여 배당체 성분을 비당체로 변화시킴으로써 유효성분의 항산화활성을 높이고, 장내 흡수를 촉진시켜 약효를 증대시킬 수 있도록 하였다. In the process of extracting and concentrating a herbal medicine ingredient from a triplex, the enzyme-yeast complex is used to increase the antioxidant activity of the active ingredient and to increase the drug efficacy by promoting intestinal absorption.
또한, 본 발명은 효모- 효소 복합 발효액을 사용하여 삼채의 비린 냄새와 역겨운 맛을 개선하고, 항산화 활성을 증강시켜 항염효과, 고지혈증, 동맥경화, 뇌혈관 질환, 정신작용 개선, 체지방분해, 당뇨질환 등을 예방하거나 개선할 수 있다. The present invention also provides a fermented yeast-fermented yeast-fermented broth comprising a fermented yeast-enzyme fermentation liquid, which improves the odor and disgusting taste of the frog, enhances the antioxidant activity and improves anti-inflammatory activity, hyperlipidemia, arteriosclerosis, cerebrovascular disease, And the like can be prevented or improved.
본 발명의 음료는 발효삼채를 위시하여 우수한 약리 효과를 갖는 길경, 양유, 갈근 및 용안육을 배합시킴으로써 과도한 운동, 육체적 과로, 심한 무더위, 건조한 환경, 과음 등으로 인한 갈증을 해소하고 구강이 건조해지는 것을 예방하며 부족한 체내 수분을 보충할 수 있다. The beverage according to the present invention can be used in combination with ginseng, yang, pung, and yongsan which have excellent pharmacological effects such as fermented trihydrate to relieve thirst caused by excessive exercise, physical overload, severe heat, dry environment, It can prevent and supplement the insufficient body water.
도 1은 본 발명의 일 실시예에 따라 아스퍼르길러스 오리자애(Aspergillus Oryzae) 효모 및 천연효소 복합발효액을 사용하여 삼채뿌리를 발효숙성 및 건조과정을 거쳐 발효삼채를 제조하는 과정을 나타낸 단계별 흐름도이다.
도 2는 본 발명의 다른 실시에에 따라 사카로마이세스 엘립소이더스(Saccharomyces ellipsoideus) 효모 및 천연효소 복합발효액을 사용하여 삼채뿌리를 발효숙성 및 건조과정을 거쳐 발효삼채를 제조하는 과정을 나타낸 단계별 흐름도이다.
도 3은 본 발명의 또 다른 실시예에 따라 사카로마이세스 세레비시애(Saccharomyces cerevisiae) 효모 및 천연효소 복합발효액을 사용하여 삼채뿌리를 발효숙성 및 건조과정을 거쳐 발효삼채를 제조하는 과정을 나타낸 단계별 흐름도이다.
도 4는 본 발명의 실시예에 따라 생삼채 뿌리와 건조삼채 뿌리의 휘발성 유황의 함량을 나타낸 표이다.
도 5는 본 발명의 실시예에 따라 세 종류의 효모를 사용하여 발효숙성을 진행한 후 유황분석기를 통하여 발효삼채의 유황함유량을 비교한 것이다.
도 6a 및 6b는 본 발명의 실시예에 따라 세 종류의 효모를 사용하여 발효숙성을 진행한 후 DPPH방법에 따라 활성산소에 대한 수소공여능을 비교한 도면이다.
도 7a 및 7b는 본 발명의 실시예에 따라 세 종류의 효모를 사용하여 발효숙성을 진행한 후 키산틴법에 따라 수퍼옥시드라디칼에 대한 항산화활성을 비교한 도면이다.
도 8a 및 8b는 본 발명의 실시예에 따라 세 종류의 효모를 사용하여 발효숙성을 진행한 후 그리스법에 따라 NO라디칼 소거활성을 비교한 도면이다.
FIG. 1 is a flow chart showing a process of producing a fermented triplex by fermenting and sieving a root of a triplex with an aspergillus oryzae yeast and a natural enzyme complex fermentation broth according to an embodiment of the present invention. to be.
FIG. 2 is a schematic view showing a process for preparing a fermented triangle through a fermentation aging and drying process using a saccharomyces ellipsoideus yeast and a natural enzyme complex fermentation broth according to another embodiment of the present invention. FIG.
FIG. 3 shows a process for preparing fermented triangles by fermentation of fermentation and drying of triangular root using saccharomyces cerevisiae yeast and natural enzyme complex fermentation broth according to another embodiment of the present invention FIG.
FIG. 4 is a table showing the content of volatile sulfur in fresh root and root dry root according to an embodiment of the present invention. FIG.
FIG. 5 is a graph comparing sulfur content of a fermented triangle with a sulfur analyzer after fermentation aging using three kinds of yeasts according to an embodiment of the present invention.
FIGS. 6A and 6B are graphs showing the hydrogen donating ability for active oxygen according to the DPPH method after fermentation aging using three kinds of yeasts according to an embodiment of the present invention. FIG.
FIGS. 7A and 7B are graphs showing antioxidative activities against superoxide radicals according to the kyphanthin method after fermentation aging using three kinds of yeasts according to an embodiment of the present invention. FIG.
FIGS. 8A and 8B are graphs comparing NO radical scavenging activity according to the grease method after fermentation aging using three kinds of yeasts according to an embodiment of the present invention. FIG.
도 1 내지 도 3은 본 발명의 발효 삼채 제조방법을 보여준다. 본 발명의 발효 삼채 제조방법은 복합발효액을 삼채에 침지시키는 단계, 발효 단계, 숙성 단계 및 건조 단계를 포함한다. 1 to 3 show a method for manufacturing the fermented triangle according to the present invention. The method for manufacturing a fermented triangle according to the present invention includes a step of immersing the complex fermentation broth in a triplex, a fermentation step, an aging step and a drying step.
먼저, 본 발명은 효모 배양 농축분말과 과일효소 농축액을 혼합한 효모-효소 복합 발효액을 제조하는 단계를 포함한다. First, the present invention includes a step of preparing a yeast-enzyme complex fermentation broth by mixing a concentrated yeast culture powder and a fruit enzyme concentrate.
도 1 내지 도 3을 참고하면, 효모-효소 복합 발효액은 하기 과정을 거친다. 3종의 효모 분말은 먼저 각각의 효모를 배지에 접종하고 계대배양을 통하여 증균시킨 후 여기에 유당을 가하고 동결건조시켜 분말화한다. 또한, 천연효소는 미숙성 월하시에 백당을 혼합하고 이를 6개월 발효후 여과 농축을 하여 수득한다. 1 to 3, the yeast-enzyme complex fermentation broth is subjected to the following process. Three yeast powders were prepared by first inoculating each yeast into a medium and culturing them by subculture, adding lactose thereto, and lyophilizing the mixture. In addition, the natural enzyme is obtained by mixing white sugar at an immature month and fermenting it for 6 months, followed by filtration and concentration.
효모-효소 복합 발효액은 앞에서 제조한 효모 분말과 효소 농축액을 혼합하여 제조한다. The yeast-enzyme complex fermentation broth is prepared by mixing the yeast powder prepared above with an enzyme concentrate.
본 발명에서 사용가능한 효모 균주는 아스퍼르길러스 오리자애(Aspergillus Oryzae), 사카로마이세스 엘립소이더스(Saccharomyces ellipsoideus) 및 사카로마이세스 세레비시애(Saccharomyces cerevisiae) 중 어느 하나를 사용할 수 있다. The yeast strains usable in the present invention may be any one of Aspergillus oryzae, Saccharomyces ellipsoideus and Saccharomyces cerevisiae.
본 발명에서의 발효는 효모-효소 복합 발효액을 삼채에 넣고 소정시간 동안 발효시킨다. In the present invention, the yeast-enzyme complex fermentation broth is placed in a pan and fermented for a predetermined period of time.
상기 발효는 1~3차에 걸쳐 다양한 방법으로 수행될 수 있다. The fermentation can be carried out in one to three different ways.
상기 효모-효소 복합 발효액을 삼채, 바람직하게는 삼채 뿌리가 침지되도록 첨가한다. 삼채 뿌리가 침지된 상태에서 소정 시간, 바람직하게는 실온에서 하루 정도 방치시킬 수 있다. The yeast-enzyme complex fermentation broth is added in triplicate, preferably triple root, so that it is immersed. It can be allowed to stand for a predetermined time, preferably at room temperature for a day, in a state in which the triple root is immersed.
상기 1차 발효 단계는 발효조에서 수일동안 발효하는 단계이다. 예를 들면, 상기 1차 발효는 50~60℃를 유지하면서 5일 동안 발효할 수 있다. The primary fermentation step is a fermentation step for several days in a fermentation tank. For example, the primary fermentation can be fermented for 5 days while maintaining a temperature of 50 to 60 ° C.
상기 2차 발효는 상기 효모 - 효소 복합 발효액을 상기 삼채에 분사하여 발효할 수 있으며, 3차 발효는 2차 발효와 같은 조건으로 발효를 추가로 진행할 수 있다. The secondary fermentation may be performed by spraying the yeast-enzyme complex fermentation broth onto the triplex, and the fermentation may be further performed under the same conditions as the secondary fermentation in the tertiary fermentation.
상기 숙성 및 건조 단계는 다양한 방법으로 수행될 수 있지만, 바람직하게는 40~50℃의 온도에서 대류열 순환방식과 40~60%의 습도를 유지하면서 대류열을 이용한 습식가열을 통하여 3일동안 숙성시킨 후, 30~40℃에서 통풍 건조시킬 수 있다. The aging and drying steps may be carried out in various ways, but preferably at a temperature of 40 to 50 ° C, while maintaining a humidity of 40 to 60% and a convection heat cycle, Followed by air drying at 30 to 40 ° C.
본 발명은 상기 발효 삼채로부터 발효 삼채 추출액을 제조할 수 있다. 상기 추출액을 제조하는 방법은 공지된 다양한 방법, 용매 추출법, 가열 가압 추출법등을 사용할 수 있다. 예를 들면, 상기 발효삼채에 정제수를 가하고 가온 추출하여 발효 삼채 추출액을 제조할 수 있다. The present invention can produce a fermented tripe extract from the fermented triangle. As the method for producing the above extract, various known methods, solvent extraction method, heated pressure extraction method and the like can be used. For example, purified water can be added to the above-mentioned fermented triplex and heated to extract a fermented triplex extract.
본 발명은 상기 발효 삼채 추출액을 사용하여 갈증해소용 음료를 제공한다. The present invention provides thirsty beverages by using the fermented triple extract.
본 발명의 갈증해소용 음료는 상기 발효삼채 추출액 및 길경 추출액, 양유 추출액, 갈근 추출액, 용안육 추출액, 결명자 추출액 및 옥수수 추출액 중 어느 하나 이상의 추출액을 포함할 수 있다. The thirst-quenching drink of the present invention may include the fermented triangle extract, the extract of Gakkyung Extract, the Yangyu Extract, the Puerariae Extract, the Piglet Extract, the Defoliation Extract, and the Corn Extract.
좀 더 구체적으로는 길경, 양유 및 갈근을 복합하여 혼합추출액을 제조하고, 또한, 용안육추출액, 결명자 추출액과 옥수수추출액을 제조한다. 상기 추출액을 상기 발효 삼채 추출액에 소정 비율로 혼합하여 갈증해소 음료를 제조할 수 있다. More specifically, a mixed extract is prepared by combining Gyungyang, Yangyu, and Pueraria roots, and further, a yongtan extract, a lucifer extract and a corn extract are prepared. The extract can be mixed with the fermented triangle extract at a predetermined ratio to produce a thirst-free beverage.
상기 음료는 조제용기에 시클로덱스트린 시럽, 정제수 및 상기 발효삼채 추출액이 혼합되어 반응된 용액을 사용할 수 있다. 좀 더 구체적으로, 조제용기에 먼저 시클로덱스트린시럽과 정제수를 넣어 가온하고 여기에 발효삼채 추출액을 넣고 반응시키고, 이어서, 상기 길경, 양유, 갈근의 혼합 추출액과 용안육추출액을 순차적으로 가한 후 올리고당 및 아가베시럽을 가한다. 여기에 볶은 결명자와 볶은 옥수수로부터 수득한 추출액을 가하고, 온도를 높여 박하향을 첨가한다. 혼합액을 실온에서 서서히 냉각시켜 마이크로필터로 여과하면 혼합음료를 완성할 수 있다. The beverage may be a solution prepared by mixing cyclodextrin syrup, purified water, and the fermented triplex extract in a preparation container. More specifically, cyclodextrin syrup and purified water were first added to the preparation vessel, and the fermented triplex extract was added thereto, followed by reaction. Subsequently, the mixed extracts of the above-mentioned gyeonggyeol, soybean oil, Syrup is added. To this, an extract obtained from roasted killer and roasted corn is added, and the temperature is raised to add the peppermint. The mixed solution is slowly cooled at room temperature and filtered with a microfilter to complete the mixed beverage.
본 발명에서 사용되는 길경, 양유, 갈근, 용안육의 특성은 아래와 같다. The characteristics of gyeonggyeong, soybean oil, rice gruel, and dragon grass used in the present invention are as follows.
길경(Platycodi Radix)은 도라지(Platycodon grandiflorum)의 뿌리 또는 주피를 제거한 것으로써 냄새가 약간 있고 맛은 처음에는 없으나 나중에는 아리고 쓰다. 길경의 함유성분은 대략 사포닌(Saponin) 약 2%, 루판계 트리테르페노이드(Lupan계 triterpenoid) 및 피토스테롤(Phytosterol)로 대별된다. Platycodi radix is the root of the bellflower (Platycodon grandiflorum). It has a little odor. It has no taste at first, but later it is arigo. The ingredients of Gyungyang are roughly classified into 2% saponin, lupan triterpenoid and phytosterol.
사포닌 성분으로는 플라티코딘(platycodin A, C, D), 플라티코디게닌산(platycodigenic acid A, C) 폴리갈라신산(polygalacic acid), 폴리갈라신(polygalacin D) 등을 함유하고, 루판계 트리테르페노이드 성분으로는 베툴린(betulin) 등을 함유하며 피토스테롤 성분으로는 알파스피나스테롤(α-spinasterol), 알파스피나스테롤 글루코시드(α-spinasterol glucoside) 등을 함유하고 있다. Examples of the saponin component include platycodin A (C, D), platycodigenic acid A (C), polygalacic acid, polygalacin D, The terpenoid ingredient includes betulin and the like. The phytosterol ingredient includes alpha-spinasterol, alpha-spinasterol glucoside, and the like.
길경은 위 점막을 자극하고 기관지 분비를 촉진하여 거담작용을 나타내고 진통작용, 혈당강하작용, 말초혈관 확장작용, 용혈작용, 간장 내 콜레스테롤 함량저하, 항궤양작용 및 항염작용을 나타낸다. 길경은 한방에서 길경탕, 길경백산 등으로 처방되어 진해거담약으로 기침, 기관지염에 널리 쓰이고, 아울러 배농약으로 화농성질환, 인후통에도 사용된다. Gakgyeong stimulates the gastric mucosa and promotes bronchial secretion, and exhibits a goddess effect and exhibits analgesic action, hypoglycemic action, peripheral vasodilatory action, hemolytic action, reduced cholesterol content in the liver, anti-ulcerative action and anti-inflammatory action. Gyeonggyeong is prescribed in Ganggyeongtang and Gilbyeongsan in the oriental medicine. It is widely used for cough, bronchitis, and also as a pesticide for purulent diseases and sore throat.
양유(Codonopsis lanceolata)는 주로 더덕으로 불려지며 한국, 일본, 중국 등지에 분포하고 뿌리는 굵으며 해발 2,000m 이상의 높은 산에서부터 들판, 구릉, 강가, 산기슭, 고원지대 등 도처에 자생하고 식물체를 자르면 흰색의 즙액이 나온다. Codonopsis lanceolata is mainly called doduck. It is distributed in Korea, Japan, China, etc., and its roots are thick. It grows everywhere from high mountain over 2,000m above sea level to fields, hills, riverside, mountainous foothills and highlands. Of juice comes out.
양유의 유효성분은 주로 트리테르페노이드계 사포닌(Triterpenoid계 saponin)으로 구성되어 있는데, 현재까지 알려진 양유의 사포닌은 란세마시드류 6종(lancemaside A, B, C, D, E, G), 포티디시모시드(foetidissimoside A), 아스터 사포닌(aster saponin Hb)으로 총 8가지이다. The saponin of soybean oil, known to date, is composed of six species of lancemaids (lancemaside A, B, C, D, E, and G) Fetidissimoside A, and aster saponin Hb in total.
양유의 효능으로는 정장작용, 해독작용, 거담작용, 용혈작용, 항균작용, 콜레스테롤 저하작용, 혈관확장작용 및 혈압강하작용을 가지고 있으며, 기침과 가래를 개선하고, 기관지염, 편도선염, 후두염에 사용되고 폐와 비장, 신장을 튼튼하게 하며 건위강장, 인후염, 폐농양, 임파선염, 유선염, 종기치료 등에 폭넓게 사용된다. The efficacy of soybean oil has the functions of suicide, detoxification, geodetic, hemolytic, antibacterial, cholesterol lowering, vasodilating and hypotensive action, improving cough and phlegm, and being used for bronchitis, tonsillitis, Spleen, and kidneys, and is widely used in the treatment of dry bowel syndrome, sore throat, lung abscess, lymphadenitis, mastitis, and boils.
갈근(Puerariae Radix)은 칡(Pueraria lobata)의 주피를 제거한 뿌리이며 냄새는 없고 맛은 약간 달다. Puerariae Radix is a root of Pueraria lobata which has no scent and taste slightly.
갈근의 유효성분은 이소플라보노이드(Isoflavonoid)로써 퓨에라린(Puerarin), 다이드진(Daidzin), 다이드제인(Daidzein), 제니스테인(Zenistein) 등을 함유하고 있고, 트리테르페노이드(Triterpenoid)로써 소이야사포닌Ⅰ(Soyasaponin Ⅰ), 소이야사포게놀 A(Soyasapogenol A) 등을 함유하고 있다. The active ingredient of Pueraria is isoflavonoid which contains Puerarin, Daidzin, Daidzein, Zenistein and others as Triterpenoid. (Soyasaponin I), Soyasapogenol A (Soyasapogenol A), and the like.
갈근의 효능은 해열작용, 진경작용, 순환계에 대한 작용, 혈당강하작용, 간세포 보호작용, 항혈전작용, 알코올 섭취억제 작용 등을 나타낸다. 또한, 몸의 진액을 보충해주는 효능이 있어 구갈과 소갈에 좋으며 과음한 후 마시면 술독을 풀어주고, 또한 살과 근육에 작용하여 근육이 뭉친 것을 풀어주며 특히 목덜미가 당기는데 효과가 있다. The efficacy of purine root shows antipyretic action, antipyretic action, action on the circulatory system, hypoglycemic action, hepatocyte protective action, antithrombotic action, and alcohol intake inhibitory action. In addition, it has the effect of supplementing the essence of the body and it is good for gogal and noise. Drinking after overdrawing frees the digestive system and also works on flesh and muscles to release the muscles, especially the nape.
상기 갈근은 말초의 혈액순환을 촉진하고 관상동맥을 확장하여 혈류량을 증가시키고 혈전을 용해함으로써 심장의 운동을 항진시킨다. 또한, 상기 갈근은 소염, 해열, 항균, 수렴 및 지사작용이 있고 근육의 경련을 억제하여 진경작용을 가지므로 고혈압, 두통, 불면증에도 효능을 나타낸다. The prawn promotes peripheral blood circulation, dilates the coronary artery to increase blood flow and dissolves thrombus to exacerbate cardiac motion. In addition, the prawn has anti-inflammatory, antipyretic, antimicrobial, astringent, and gingival actions, suppresses muscle spasms, and has an antinociceptive action, thus exhibiting effects on hypertension, headache and insomnia.
용안육(Longanae Arillus)은 용안나무의 과종피로써 특이한 냄새가 있고 맛은 달다. Longanae Arillus is an overproduction of lupine and has a peculiar odor and taste.
용안육의 유효성분은 시토스테롤(sitosterol), 다우코스테롤(daucosterol), 우라실(uracil), 아데노신(adenosine)등을 함유하고 있으며, 그 외에 수 종의 아미노산, 글루코오스, 수크로오스, 지방, 지방산, 단백질 등 영양성분을 풍부하게 함유하고 있다. The active ingredients of yonggan meat contain sitosterol, daucosterol, uracil and adenosine. In addition, various nutrients such as amino acids, glucose, sucrose, fat, Rich in ingredients.
용안육의 약리작용은 진정작용, 불안완화작용, 건위작용, 자양작용 등이 알려져 있으며 한방에서는 귀비탕으로 처방되어 진정약, 자양간장약, 건망증, 실면증 등에 사용된다. The pharmacological effects of yongganui are known to be sedative, anxiolytic, cardiovascular, and nourishing, and it is prescribed in the oriental medicine as a guinea pig, and is used for sedatives, nausea, amenorrhea, and nausea.
본 발명은 삼채로부터 생약 성분을 추출하고 농축하는 과정에서 효소-효모 복합체를 사용하여 배당체 성분을 비당체로 변화시킴으로써 유효성분의 항산화활성을 높이고, 장내 흡수를 촉진시켜 약효를 증대시킬 수 있도록 하였다. 또한, 본 발명은 효모- 효소 복합 발효액을 사용하여 삼채의 비린 냄새와 역겨운 맛을 개선하고, 항산화 활성을 증강시켜 항염효과, 고지혈증, 동맥경화, 뇌혈관 질환, 정신작용 개선, 체지방분해, 당뇨질환 등을 예방하거나 개선할 수 있다. In the process of extracting and concentrating a herbal medicine ingredient from a triplex, the enzyme-yeast complex is used to increase the antioxidant activity of the active ingredient and to increase the drug efficacy by promoting intestinal absorption. The present invention also provides a fermented yeast-fermented yeast-fermented broth comprising a fermented yeast-enzyme fermentation liquid, which improves the odor and disgusting taste of the frog, enhances the antioxidant activity and improves anti-inflammatory activity, hyperlipidemia, arteriosclerosis, cerebrovascular disease, And the like can be prevented or improved.
본 발명의 음료는 발효삼채를 위시하여 우수한 약리 효과를 갖는 길경, 양유, 갈근 및 용안육을 배합시킴으로써 과도한 운동, 육체적 과로, 심한 무더위, 건조한 환경, 과음 등으로 인한 갈증을 해소하고 구강이 건조해지는 것을 예방하며 부족한 체내 수분을 보충할 수 있다. The beverage according to the present invention can be used in combination with ginseng, yang, pung, and yongsan which have excellent pharmacological effects such as fermented trihydrate to relieve thirst caused by excessive exercise, physical overload, severe heat, dry environment, It can prevent and supplement the insufficient body water.
본 발명의 실시예들의 목적은 이상에서 언급한 목적으로 제한되지 않으며, 언급되지 않은 또 다른 목적들은 아래의 기재로부터 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에게 명확하게 이해될 수 있을 것이다.
The objects of the embodiments of the present invention are not limited to the above-mentioned objects, and other objects not mentioned can be clearly understood by those skilled in the art from the following description .
[실시예 1][Example 1]
먼저 아스퍼르길러스 오리자애(Aspergillus Oryzae) 효모 배양 농축분말(1.0× 109cfu/g) 2g에 정제수 50㎖를 가하여 균질하게 혼합한 효모 발효액을 제조하였다. 한편, 과일 효소 농축액 1g에 정제수 50㎖를 가하여 균질하게 혼합한 천연효소배양액을 제조하였다. 효모 발효액과 천연효소 배양액을 혼합하고, 여기에 정제수 900㎖를 넣어 1,000㎖의 효모-천연효소 복합 발효액을 만들었다. First, 50 ml of purified water was added to 2 g of Aspergillus Oryzae yeast culture concentrated powder (1.0 x 10 < 9 > cfu / g) to prepare yeast fermentation solution homogeneously mixed. On the other hand, 50 ml of purified water was added to 1 g of the fruit enzyme concentrate to prepare a homogeneously mixed natural enzyme culture. The yeast fermentation broth was mixed with the natural enzyme culture, and 900 ml of purified water was added thereto to prepare 1,000 ml of the yeast-natural enzyme complex fermentation broth.
삼채뿌리를 70℃에서 12시간동안 건조한 후 건조 삼채뿌리 500g을 취하여 발효용 트레이에 넣고 효모 - 천연효소 복합 발효액 500㎖를 넣어 침지한 후, 실온에서 24시간동안 방치시켰다. 이것을 발효조에 넣고 50~60℃를 유지하면서 5일 동안 1차 발효시키고, 다시 효모-천연효소 복합 발효액 250㎖를 분사한 후 동일한 조건에서 2차 발효를 진행하고, 또 다시 효모-천연효소 복합 발효액 250㎖를 분사한 후 3차 발효를 진행하였다. The dried root was dried at 70 ° C for 12 hours, and 500 g of the dry triangular root was taken and placed in a fermentation tray. The mixture was immersed in 500 ml of yeast-natural enzyme complex fermentation broth, and left at room temperature for 24 hours. The resulting mixture was put into a fermenter and subjected to primary fermentation for 5 days while maintaining the temperature at 50 to 60 ° C. Then, 250 ml of yeast-natural enzyme complex fermentation broth was sprayed, and the fermentation was performed under the same conditions. 250 ml was injected and the third fermentation was carried out.
3차 발효 후 40~50℃의 온도에서 대류열 순환방식과 40~60%의 습도를 유지하면서 대류열을 이용한 습식가열을 통하여 3일 동안 숙성시킨 후, 30~40℃에서 통풍 건조시켜 발효삼채를 얻었다. After the third fermentation, it was aged for 3 days by convection heat circulation method and maintaining the humidity of 40 ~ 60% at a temperature of 40 ~ 50 ℃ and convection heat for 3 days. Then, it was ventilated at 30 ~ .
발효삼채 500g에 정제수 10.0ℓ를 가하고 95~100℃에서 4시간 동안 가온추출하고 농축하여 10% 발효삼채추출액을 만들었다. 10.0 L of purified water was added to 500 g of the fermented triplex, heated at 95 to 100 ° C for 4 hours and concentrated to obtain a 10% fermented triple extract.
길경 200g, 양유100g 및 갈근 50g을 혼합한 후 정제수 7.0ℓ를 넣어 동일한 조건으로 가온 추출하여 10% 길경, 양유, 갈근 혼합추출액을 제조였다. 200 g of Gyungyang, 100 g of soybean oil and 50 g of Pueraria japonica were mixed and 7.0 ℓ of purified water was added and heated under the same conditions to prepare 10% Gypsum, Yangyu and Puerariae mixed extracts.
용안육 100g을 취하고 정제수 2.0ℓ를 가하여 동일조작으로 10% 용안육추출액을 만들었다. 100 g of canine pancreas was taken and 2.0 L of purified water was added thereto to prepare 10% canola extract.
별도로 볶은 결명자 및 볶은 옥수수 500g씩 각각의 추출용기에 넣고 정제수 10ℓ를 가하여 동일조작으로 10% 볶은 결명자추출액 및 10% 볶은 옥수수추출액을 제조하였다. Separately, 500 g of roasted cuttlefish and roasted corn were placed in each extraction container, and 10 L of purified water was added thereto to prepare 10% roasted lucifer extract and 10% roasted corn extract by the same procedure.
조제용기에 먼저 정제수 2.5ℓ와 시클로덱스트린시럽 50㎖를 넣어 가온하고 여기에 10% 발효삼채추출액 100g을 넣고 70~80℃에서 20분 동안 반응시킨 후, 10% 길경, 양유, 갈근 혼합추출액 350㎖와 10% 용안육추출액 200㎖를 순차적으로 가한 후, 올리고당 320g, 아가베시럽 200g 및 정제수 500㎖를 가하였다. 여기에 10% 볶은 결명자 150㎖, 10% 볶은 옥수수추출액 250㎖ 및 정제수 300㎖를 가하고 90~100℃에서 20분 동안 가온한 후, 50% 박하오일, 에탄올 용액 10㎖를 적가하고, 실온에서 서서히 냉각시켜 온시에 마이크로필터로 여과하여 갈증해소 음료를 제조하였다.
2.5 liters of purified water and 50 ml of cyclodextrin syrup were added to the preparation vessel and heated to 70 to 80 ° C for 20 minutes. Then, the mixture was mixed with 10% And 200 ml of 10% Phellinus linteus extract were sequentially added, and then 320 g of oligosaccharide, 200 g of agave syrup and 500 ml of purified water were added. 150 ml of 10% roasted cuttlefish, 250 ml of 10% roasted corn extract and 300 ml of purified water were added and the mixture was heated at 90 to 100 ° C for 20 minutes. 10 ml of 50% peppermint oil and ethanol solution was added dropwise thereto, The mixture was cooled and filtered with a microfilter at the on-time to prepare a thirst-quenching beverage.
[실시예 2][Example 2]
효모로 사카로마이세스 엘립소이더스(Saccharomyces ellipsoideus) 효모 배양 농축분말을 사용한 것을 제외하고 실시예 1과 동일하게 수행하였다.
The same procedure as in Example 1 was carried out except that Saccharomyces ellipsoideus yeast culture concentrated powder was used as a yeast.
[실시예 3][Example 3]
효모로 사카로마이세스 세레비시애(Saccharomyces cerevisiae) 효모 배양 농축분말을 사용한 것을 제외하고 실시예 1과 동일하게 수행하였다.
The procedure of Example 1 was repeated except that Saccharomyces cerevisiae yeast culture concentrated powder was used as the yeast.
도 4는 본 발명의 실시예에 따라 삼채뿌리의 휘발성 유황의 함량을 비교한 도면으로써 상술한 바와 같은 과정에 따라 생삼채 뿌리 및 건조삼채 뿌리 중에 함유된 휘발성 유황을 분석한 결과에 대해 설명한다. FIG. 4 is a graph comparing the contents of volatile sulfur in the three-rooted root according to the embodiment of the present invention. The results of analysis of the volatile sulfur contained in the root and the dried three-rooted root according to the procedure described above will be described.
GC/MS 분석결과 휘발성 유황의 성분은 알릴 메칠 설파이드(Allyl methyl sulfide)를 위시하여 총 23종의 휘발성 유황이 검출되었으며 생삼채 뿌리의 총 휘발성 유황은 0.735%를 함유하고 있고, 70℃에서 12시간 건조한 삼채뿌리는 0.535%의 총 휘발성 유황을 함유함으로써 건조과정을 통하여 약 27%의 휘발성 유황이 감소된 것으로 나타났다. As a result of GC / MS analysis, 23 kinds of volatile sulfur such as allyl methyl sulfide were detected in the volatile sulfur component, and the total volatile sulfur content of the raw thrips contained 0.735% The dry trilobal roots contained 0.535% total volatile sulfur, indicating that about 27% of the volatile sulfur was reduced through the drying process.
도 5는 본 발명의 실시예에 따라 세 종류의 효모를 사용하여 발효숙성을 진행한 후 유황분석기를 통하여 발효삼채의 총 유황함유량을 비교한 결과에 대하여 설명한다. FIG. 5 illustrates the result of comparing the total sulfur content of the fermented triangle through a sulfur analyzer after fermentation aging using three kinds of yeasts according to an embodiment of the present invention.
건조삼채의 유황함유량이 0.535%인데 비하여 아스퍼르길러스 오리자애(Aspergillus Oryzae)는 0.362%, 사카로마이세스 엘립소이더스(Saccharomyces ellipsoideus)는 0.39%로 나타났으나, 사카로마이세스 세레비시애(Saccharomyces cerevisiae)는 0.425%로써 가장 높은 유황함유량을 보여주었다. Aspergillus oryzae was found to be 0.362% and Saccharomyces ellipsoideus was found to be 0.39%, compared with 0.535% of the sulfur content of the dry trilobites. However, (Saccharomyces cerevisiae) showed the highest sulfur content as 0.425%.
도 6a 및 6b는 본 발명의 실시예에 따라 세 종류의 효모를 사용하여 발효숙성을 진행한 후 DPPH방법에 따라 활성산소에 대한 수소공여능을 비교한 결과에 대해 설명한다. FIGS. 6A and 6B illustrate results of comparing the hydrogen donating ability with respect to the active oxygen according to the DPPH method after progressing fermentation using three kinds of yeasts according to an embodiment of the present invention. FIG.
그 실험 방법은 0.2mM DPPH 메탄올 용액 0.5mL 에 시료를 여러 농도로 희석한 용액 1mL를 가하고, 교반기로 10초간 진탕한 후 20℃에서 30분간 방치한 다음 517nm에서 흡광도를 측정하였다. 여기에서, 비교 표준물질로는 비타민 C를 사용하였다. The test was carried out by adding 1 mL of a diluted sample solution to 0.5 mL of a 0.2 mM DPPH methanol solution, shaking it for 10 seconds with an agitator, incubating at 20 ° C for 30 minutes, and measuring the absorbance at 517 nm. Here, vitamin C was used as a reference material for comparison.
활성의 크기는 DPPH(66.7uM)의 농도가 50% 감소되는데 필요한 시료의 농도(Free Radical Scavenging Activity, FSC50, ug/mL)와 DPPH에 대한 전자 공여능(Electron Donating Ability, EDA%)으로 아래의 수학식 1과 같이 나타내었다.The size of the activity was determined by measuring the concentration of free radical scavenging activity (FSC 50, ug / mL) and the electron donating ability (EDA%) for DPPH in which the concentration of DPPH (66.7 uM) 1 < / RTI >
여기에서, Sample ABS는 시료를 가한 시험액의 흡광도를 나타내고, Control ABS는 시료 대신 메탄올을 가한 시험액의 흡광도를 나타낸다.Here, Sample ABS represents the absorbance of the test liquid to which the sample is added, and Control ABS represents the absorbance of the test liquid to which methanol is added instead of the sample.
500㎍/mL 농도에서 건조삼채의 DPPH에 대한 수소공여능은 7.2%, 아스퍼르길러스 오리자애(Aspergillus Oryzae)는 15.6%, 사카로마이세스 엘립소이더스(Saccharomyces ellipsoideus)는 21.0%로 나타나 건조삼채에 비하여 비교적 높은 수치를 보여주었으며, 사카로마이세스 세레비시애(Saccharomyces cerevisiae)는 44.8%로 나타나 건조삼채에 비하여 6배 이상 항산화활성이 증강되었다. At the concentration of 500 μg / mL, the hydrogen donating ability to dry DPPH was found to be 7.2%, 15.6% for Aspergillus oryzae and 21.0% for Saccharomyces ellipsoideus, And 44.8% of Saccharomyces cerevisiae showed higher antioxidant activity than that of dry triplicate.
도 7a 및 7b는 본 발명의 실시예에 따라 세 종류의 효모를 사용하여 발효숙성을 진행한 후 키산틴법에 따라 수퍼옥시드라디칼에 대한 항산화활성을 비교한 결과에 대해 설명한다. FIGS. 7A and 7B illustrate the results of comparing the antioxidative activity against the superoxide radicals according to the kyphanthin method after fermentation aging using three kinds of yeasts according to an embodiment of the present invention.
그 실험 방법은 NBT(Nitro Blue Tetrazoliun) 및 키산틴(1.6mM)의 완충용액(20mM, pH 7.8)에 키산틴 옥시다제(0.05U/mL)100μL 적가하면서 37℃에서 30분간 배양한 후 분광광도계로 517nm에서 흡광도를 사용하여 NBT 환원능력을 측정하였다. The experiment was carried out at 37 ° C for 30 minutes while adding 100 μL of xanthine oxidase (0.05 U / mL) to a buffer solution (20 mM, pH 7.8) of NBT (Nitro Blue Tetrazoliun) The absorbance at 517 nm was used to determine the NBT reduction capacity.
50㎍/mL 농도에서 건조삼채의 키산틴법에 의한 수퍼옥시드라디칼에 대한 항산화활성은 18.9%인 반면 아스퍼르길러스 오리자애(Aspergillus Oryzae)는 32.7%, 사카로마이세스 엘립소이더스(Saccharomyces ellipsoideus)는 37.4%로 나타나 건조삼채에 비하여 비교적 높은 수치를 보여주었으며, 사카로마이세스 세레비시애(Saccharomyces cerevisiae)는 55.7%로 나타나 건조삼채에 비하여 약 3배 이상 항산화활성이 증강되었다. At 50 μg / mL concentration, the antioxidant activity against the superoxide radical by the xanthine method of dried triplex was 18.9%, while Aspergillus oryzae was 32.7%, Saccharomyces ellipsoideus ) Was 37.4%, which was relatively higher than that of dry triplicate. The antioxidant activity of Saccharomyces cerevisiae was 55.7%, which was about 3 times higher than that of dry triplicate.
도 8a 및 8b는 본 발명의 실시예에 따라 세 종류의 효모를 사용하여 발효숙성을 진행한 후 그리스법에 따라 NO라디칼 소거활성을 비교한 결과이다. FIGS. 8A and 8B are graphs showing the NO radical scavenging activity according to the grease method after fermentation aging using three kinds of yeasts according to an embodiment of the present invention. FIG.
그 실험 방법은 소디움 니트로프루시드 용액(10mM)에 시료를 가하고, 그리스시액(0.2% 나프칠에칠렌디아민염산, 2% 설파닐아미드,5% 인산용액)에 교반기로 10초간 진탕한 후 20℃에서 2시간 방치한 다음 570nm에서 흡광도를 측정하였다. 여기에서, 비교 표준물질로는 비타민 C를 사용하였다. The test was carried out by adding a sample to a sodium nitroprusside solution (10 mM), shaking it in a grease solution (0.2% naphthenic ethylenediamine hydrochloride, 2% sulfanilamide, 5% phosphoric acid solution) for 10 seconds with a stirrer, After standing for 2 hours, the absorbance was measured at 570 nm. Here, vitamin C was used as a reference material for comparison.
50㎍/mL 농도에서 건조삼채의 그리스법에 따른 NO라디칼 소거활성은 25.7%인 반면 아스퍼르길러스 오리자애(Aspergillus Oryzae)는 27.6%, 사카로마이세스 엘립소이더스(Saccharomyces ellipsoideus)는 31.4%로 나타나 건조삼채에 비하여 약간 상승하였고, 사카로마이세스 세레비시애(Saccharomyces cerevisiae)는 45.7%로 나타나 건조삼채에 비하여 약 2배 이상 항산화활성이 증강되었다.
At the concentration of 50 ㎍ / mL, the NO radical scavenging activity of the dry trilobal greens was 25.7%, while that of Aspergillus oryzae was 27.6% and that of Saccharomyces ellipsoideus was 31.4% And 45.7% of Saccharomyces cerevisiae showed that the antioxidant activity was increased more than twice as much as that of dry triplicate.
상술한 바와 같이 본원 발명의 실시예에 따른 효모 및 천연효소 복합액으로 발효숙성시킨 발효삼채는 발효하지 않은 건조삼채에 비하여 휘발성 유황의 함량이 감소하였으나, 활성산소에 대한 항산화활성이 월등하게 증가되었고 그 중 사카로마이세스 세레비시애(Sacchromyces cerevisiae)를 사용한 발효삼채가 발효하지 않은 건조삼채 및 타 효모에 비하여 훨씬 높은 성적을 나타내었다.
As described above, according to the embodiment of the present invention, the fermented trihydes fermented and aged with the yeast and natural enzyme complexes showed a decrease in the content of volatile sulfur compared with the non-fermented dry trials, but the antioxidative activity against active oxygen was significantly increased Among them, the fermented triplicate of Sacchromyces cerevisiae showed much higher performance than those of non - fermented dried triplet and other yeast.
이상의 설명에서는 본 발명의 다양한 실시예들을 제시하여 설명하였으나 본 발명이 반드시 이에 한정되는 것은 아니며, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자라면 본 발명의 기술적 사상을 벗어나지 않는 범위 내에서 여러 가지 치환, 변형 및 변경이 가능함을 쉽게 알 수 있을 것이다. While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed embodiments, but, on the contrary, It will be readily apparent that such substitutions, modifications, and alterations are possible.
Claims (5)
상기 삼채를 발효시키는 단계 ; 및
발효된 삼채를 소정 시간 숙성시킨 후 건조하는 단계를 포함하는 발효삼채 제조방법.A step of putting a yeast-enzyme complex fermentation liquid mixed with a concentrated yeast culture powder and a fruit enzyme concentrate into a three-chambered dish;
Fermenting the trifoliate; And
And aging the fermented trihydrate for a predetermined period of time, followed by drying.
상기 발효삼채 추출액 및
길경 추출액, 양유 추출액, 갈근 추출액, 용안육 추출액, 결명자 추출액 및 옥수수 추출액 중 어느 하나 이상의 추출액을 포함하는 것을 특징으로 하는 갈증해소용 음료. The method of Claim 3, wherein the beverage comprises
The fermented triplex extract and /
Wherein the extract contains at least one extract of Gakyung Extract, Yangyu Extract, Puerariae Radix Extract, Yuan Yuan Extract, Kidney Extract, and Corn Extract.
[Claim 5] The beverage according to claim 4, wherein the beverage is the solution in which the extract is added to a solution prepared by mixing cyclodextrin syrup, purified water and the fermented triplex extract in a preparation container.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140154145A KR101663379B1 (en) | 2014-11-07 | 2014-11-07 | MANUFACTURE OF FERMENTED Allium hookeri FROM YEASTS AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140154145A KR101663379B1 (en) | 2014-11-07 | 2014-11-07 | MANUFACTURE OF FERMENTED Allium hookeri FROM YEASTS AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20160055292A true KR20160055292A (en) | 2016-05-18 |
KR101663379B1 KR101663379B1 (en) | 2016-10-07 |
Family
ID=56113186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140154145A KR101663379B1 (en) | 2014-11-07 | 2014-11-07 | MANUFACTURE OF FERMENTED Allium hookeri FROM YEASTS AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101663379B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200000743A (en) * | 2018-06-25 | 2020-01-03 | (주)코엔바이오 | A composition for improving diabetes or for use of antioxidant comprising yeast extract and a method for preparing the yeast extract |
KR20210154583A (en) * | 2020-06-12 | 2021-12-21 | 대한민국(농촌진흥청장) | Pharmaceutical composition for preventing or treating degenerative brain disease comprising an extract of Allium hookeri |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101782969B1 (en) | 2015-06-10 | 2017-09-28 | 대한민국(농촌진흥청장) | Composition comprising fermented Allium hookeri for preventing and treating obesity |
KR101903633B1 (en) * | 2016-10-31 | 2018-10-04 | 농업회사법인 황금나무(주) | Method for producing fermented Allium hookeri using blueberry solution fermented by lactic acid bacteria |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110058398A (en) * | 2009-11-26 | 2011-06-01 | 강곤태 | The method of manufacturing a plant complex acid ferment solution and use thereof |
KR20140056802A (en) * | 2012-10-31 | 2014-05-12 | 주식회사 해림후코이단 | Functional fermented food and the manufacturing method thereof |
KR20140093437A (en) * | 2013-01-18 | 2014-07-28 | 주식회사 네츄로바이오 | Composition of the fermented extract of plants with dandelion for protection of hepatic functions |
-
2014
- 2014-11-07 KR KR1020140154145A patent/KR101663379B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110058398A (en) * | 2009-11-26 | 2011-06-01 | 강곤태 | The method of manufacturing a plant complex acid ferment solution and use thereof |
KR20140056802A (en) * | 2012-10-31 | 2014-05-12 | 주식회사 해림후코이단 | Functional fermented food and the manufacturing method thereof |
KR20140093437A (en) * | 2013-01-18 | 2014-07-28 | 주식회사 네츄로바이오 | Composition of the fermented extract of plants with dandelion for protection of hepatic functions |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200000743A (en) * | 2018-06-25 | 2020-01-03 | (주)코엔바이오 | A composition for improving diabetes or for use of antioxidant comprising yeast extract and a method for preparing the yeast extract |
KR20210154583A (en) * | 2020-06-12 | 2021-12-21 | 대한민국(농촌진흥청장) | Pharmaceutical composition for preventing or treating degenerative brain disease comprising an extract of Allium hookeri |
Also Published As
Publication number | Publication date |
---|---|
KR101663379B1 (en) | 2016-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101245307A (en) | Melon and fruit vinegar and manufacture method thereof | |
JP4616413B1 (en) | Fermented food manufacturing method and fermented food | |
CN103431484A (en) | Asparagus fermented beverage and preparation method thereof | |
JP4599426B2 (en) | Method for producing health food based on garlic | |
KR101663379B1 (en) | MANUFACTURE OF FERMENTED Allium hookeri FROM YEASTS AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST | |
KR101909423B1 (en) | Manufacturing method of low salinity toenjang | |
CN103431292B (en) | Health care noodle containing bullacta exarata polypeptides and plant extract powder | |
KR102062989B1 (en) | Method for producing vinegar jelly for diet using healthful food powder | |
CN1687361A (en) | Tea trea flower wine and preparation method thereof | |
KR20160059137A (en) | MANUFACTURE OF FERMENTED Alliumhookeri FROM LACTIC ACID BACTERIA AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST | |
CN108420064A (en) | Preparation method of rose and persimmon composite enzyme | |
KR20190071017A (en) | Manufacturing method of Health Food using honeybee pollen | |
KR20120071932A (en) | Lactic acid fermented solution of wild plant with enhanced antioxidative and antihypertensive activity | |
KR102507651B1 (en) | Fermented Stauntonia hexaphylla for hangover relief, alcoholic liver disease or liver function improvement using fermented enzyme complex solution containing traditional brewery yeast and its manufacturing method | |
CN105713762A (en) | Method for brewing pear health care wine without addition of sulfur dioxide | |
KR20110098080A (en) | Method for producing health food containing honeybee pollen fermented solution, propolis, honey and royal jelly | |
KR102070507B1 (en) | Manufacturing method for samgyetang using black ginseng and samgyetang using black ginseng manufactured by the same | |
CN105441278B (en) | A kind of method of thorny elaeagnus fruit deep processing | |
CN107488557A (en) | A kind of astragalus root medical liquor and preparation method | |
CN104726320B (en) | A kind of fig honey vinegar and preparation method | |
KR102085713B1 (en) | Method for producing vinegar foaming tablet for diet | |
KR20070097386A (en) | Manufacturing method of low-salt soybean paste which adds mushroom and angelica-gigas-nakai | |
CN101485455A (en) | Method for making pine mushroom wine | |
KR20070034801A (en) | Preparation of Chaga Fermented Beverage with High Hazardous Oxygen Removal Capacity | |
CN108740969A (en) | A kind of wheat sauce and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |